Diagnosis and treatment of allergic rhinitis due to house-dust mites in Spain

American Journal of Rhinology and Allergy

Volumn 26, Issue 1, 2012, Pages 23-26

  Valero, Antonio ^a   Justicia, José L ^b   Vidal, Carmen ^c   Rodríguez, Virginia ^c   Muñoz, Rosa ^a   García, Mario A ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b Sant Joan Despi   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CHROMONE DERIVATIVE; CORTICOSTEROID; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; MONTELUKAST; VASOCONSTRICTOR AGENT;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; HOUSE DUST ALLERGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL SPECIALIST; OBSERVATIONAL STUDY; PHARMACEUTICAL CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRESCRIPTION; PRICK TEST; QUESTIONNAIRE; SCHOOL CHILD; SPAIN; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY;

ADOLESCENT; ADULT; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DESENSITIZATION, IMMUNOLOGIC; DISEASE PROGRESSION; FEMALE; GUIDELINE ADHERENCE; HUMANS; IMMUNOGLOBULIN E; MALE; PHYSICIAN'S PRACTICE PATTERNS; PYROGLYPHIDAE; QUESTIONNAIRES; RHINITIS, ALLERGIC, PERENNIAL; SPAIN; YOUNG ADULT;

EID: 84857695808     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2012.26.3695     Document Type: Article

References (32)

1. Burney P, Chinn S, Jarvis D, et al. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J 9:687-695, 1996. (Pubitemid 26167872)
2. Bauchau V, and Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24:758-764, 2004. (Pubitemid 39504428)
3. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and Its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
4. Greiner AN, and Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol 118:985-998, 2006.
5. Bousquet J, Lockey R, and Malling HJ. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102:558-562, 1998.
6. Sheikh A, Hurwitz B, Nurmatov U, et al. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 4:CD001563, 2001.
7. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 55:116-134, 2000. (Pubitemid 30106016)
8. Navarro A, Col{acute]as C, Antón E, et al. Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergológica-2005. J Investig Allergol Clin Immunol 19(suppl 2):7-13, 2009.
9. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31:143-178, 2008.
10. Thompson AK, Juniper E, and Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 85:338-347, 2000.
11. Greisner WA III, Settipane RJ, and Settipane GA. Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy Asthma Proc 19:185-188, 1998. (Pubitemid 128684482)
12. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc 31:375-380, 2010.
13. Jung YG, Cho HJ, Park GY, et al. Comparison of the skin-prick test and Phadia ImmunoCAP as tools to diagnose house-dust mite allergy. Am J Rhinol Allergy 24:226-229, 2010.
14. Haughney J, Price D, Kaplan A, et al. Achieving asthma control in practice: Understanding the reasons for poor control. Respir Med 102:1681-1693, 2008.
15. Nolte H, Nepper-Christensen S, and Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med 100:354-362, 2006. (Pubitemid 43078990)
16. Marple BF. Allergic rhinitis and inflammatory airway disease: Interactions within the unified airspace. Am J Rhinol Allergy 24:249-254, 2010.
17. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol 101:S352-S356, 1998.
18. HealthStar Communications, Inc., in partnership with Schulman, Ronca, and Bucuvalas, Inc. Allergies in America: A Landmark Survey of Nasal Allergy Sufferers. Executive Summary. Florham Park, NJ: Altana Pharma US, Inc., March, 2006.
19. Valero A, Justicia J, Anton E, et al. Epidemiology of allergic rhinitis caused by grass pollen or house-dust mites in Spain. Am J Rhinol Allergy 25:e123-e128, 2011.
20. Casale TB, Blaiss MS, Gelfand E, et al. Antihistamine Impairment Roundtable. First do no harm: Managing antihistamine impairment in patients with allergic rhinitis. J Allergy Clin Immunol 111:S835-S842, 2003. (Pubitemid 36570885)
21. Weiner JM, Abramson MJ, and Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: Systematic review of randomised controlled trials. BMJ 317:1624-1629, 1998. (Pubitemid 28554544)
22. Wilson AM, O'Byrne PM, and Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: A systematic review and metaanalysis. Am J Med 116:338-344, 2004. (Pubitemid 38230294)
23. Graf P. Rhinitis medicamentosa: A review of causes and treatment. Treat Respir Med 4:21-29, 2005. (Pubitemid 40372068)
24. Grossman J, Halverson PC, Meltzer EO, et al. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis. Ann Allergy 73:141-146, 1994. (Pubitemid 24253505)
25. Sheikh A, Hurwitz B, Nurmatov U, et al. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 7:CD001563, 2010.
26. Terreehorst I, Hak E, Oosting AJ, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med 349:237-246, 2003. (Pubitemid 36859475)
27. Calderon M, Alves B, Jacobson M, et al. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database Syst Rev 24:CD001936, 2007.
28. Amin HS, Liss GM, and Bernstein DI. Evaluation of near-fatal reactions to allergen immunotherapy injections. J Allergy Clin Immunol 117:169-175, 2006. (Pubitemid 43017156)
29. Radulovic S, Calderon MA, Wilson D, and Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 12:CD002893, 2010.
30. Dunsky EH, Goldstein MF, Dvorin DJ, et al. Anaphylaxis to sublingual immunotherapy. Allergy 61:1235, 2006. (Pubitemid 44326363)
31. Gidaro GB, Marcucci F, Sensi L, et al. The safety of sublingualswallow immunotherapy: An analysis of published studies. Clin Exp Allergy 35:565-571, 2005. (Pubitemid 40769278)
32. Dykewicz MS, and Fineman S. Executive summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis. Ann Allergy Asthma Immunol 81:463-468, 1998. (Pubitemid 28553775)